THIS ENLIGHTENING AND ALARMING book deserves a wide readership among doctors but also among politicians, health administrators, and drug and medical device regulators.'

Kerry J Breen, Adjunct Professor -Department of Forensic Medicine, Monash University

Informationen zum Autor Professor Peter C Gøtzsche graduated as a Master of Science in biology and chemistry in 1974 and as a physician in 1984. He is a specialist in internal medicine; he worked with clinical trials and regulatory affairs in the drug industry 1975-83! and at hospitals in Copenhagen 1984-95. He co-founded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre the same year. He became professor of Clinical Research Design and Analysis in 2010 at the University of Copenhagen.! Peter Gøtzsche has published more than 50 papers in 'the big five' (BMJ! Lancet! JAMA! Annals of Internal Medicine and New England Journal of Medicine) and his scientific works have been cited over 10000 times.! Peter Gøtzsche has an interest in statistics and research methodology. He is a member of several groups publishing guidelines for good reporting of research and has co-authored CONSORT for randomised trials (www.consort-statement.org)! STROBE for observational studies (www.strobe-statement.org)! PRISMA for systematic reviews and meta-analyses (www.prisma-statement.org)! and SPIRIT for trial protocols (www.spirit-statement.org). Peter Gøtzsche is an editor in the Cochrane Methodology Review Group. Klappentext THIS ENLIGHTENING AND ALARMING book deserves a wide readership among doctors but also among politicians, health administrators, and drug and medical device regulators.'- Kerry J Breen, Adjunct Professor -Department of Forensic Medicine, Monash University Zusammenfassung THIS ENLIGHTENING AND ALARMING book deserves a wide readership among doctors but also among politicians, health administrators, and drug and medical device regulators.â™â Kerry J Breen, Adjunct Professor âDepartment of Forensic Medicine, Monash University Inhaltsverzeichnis Foreword by Richard Smith. Foreword by Drummond Rennie. About the author. Introduction. Confessions from an insider. Asthma deaths were caused by asthma inhalers. Shady marketing and research. Organised crime! the business model of big pharma. Hoffman-La Roche! the biggest drug pusher. Hall of Shame for big pharma. The crimes are repetitive. It's organised crime. Very few patients benefit from the drugs they take. Clinical trials! a broken social contract with patients. Conflicts of interest at medical journals. The corruptive influence of easy money. What do thousands of doctors on industry payroll do? Seeding trials. Rent a key opinion leader to 'give advice'. Rent a key opinion leader to 'educate'. Hard sell. Clinical trials are marketing in disguise. Ghostwriting. The marketing machine. Hard sell ad nauseam. Highly expensive drugs. Excesses in hypertension. Patient organisations. NovoSeven for bleeding soldiers. Impotent drug regulation. Conflicts of interest at drug agencies. Corruption at drug agencies. The unbearable lightness of politicians. Drug regulation builds on trust. Inadequate testing of new drugs. Too many warnings and too many drugs. Public access to data at drug agencies. Our breakthrough at the EMA in 2010. Access to data at other drug agencies. Deadly slimming pills. Neurontin! an epilepsy drug for everything. Merck! where the patients die first. Fraudulent celecoxib trial and other lies. Marketing is harmful. Switching cheap drugs into expensive ones in the same patients. Novo Nordisk switches patients to expensive insulin. Astra-Zeneca switches patients to expensive me-again omeprazole. Blood glucose was fine but the patients died. Novo Nordisk interferes with an academic publication. Psychiatry! the drug industry's paradise. Are we all crazy or what? Psychiatrists as drug pushers. The chemical imbalance hoax. Screening for psychiatric disorders. Unhappy pills. Prozac! a terrible Eli Lilly drug turned into a blockbuster. Exercise is a good intervention. Further lies about happy pills. Pushing children into suicide with happy pills. Glaxo study 329. Concealing suicides and suicide attempts in cli...

Autorentext
Professor Peter C Gøtzsche graduated as a Master of Science in biology and chemistry in 1974 and as a physician in 1984. He is a specialist in internal medicine; he worked with clinical trials and regulatory affairs in the drug industry 197583, and at hospitals in Copenhagen 198495. He co-founded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre the same year. He became professor of Clinical Research Design and Analysis in 2010 at the University of Copenhagen., Peter Gøtzsche has published more than 50 papers in 'the big five' (BMJ, Lancet, JAMA, Annals of Internal Medicine and New England Journal of Medicine) and his scientific works have been cited over 10000 times., Peter Gøtzsche has an interest in statistics and research methodology. He is a member of several groups publishing guidelines for good reporting of research and has co-authored CONSORT for randomised trials (www.consort-statement.org), STROBE for observational studies (www.strobe-statement.org), PRISMA for systematic reviews and meta-analyses (www.prisma-statement.org), and SPIRIT for trial protocols (www.spirit-statement.org). Peter Gøtzsche is an editor in the Cochrane Methodology Review Group.

Inhalt
Foreword by Richard Smith. Foreword by Drummond Rennie. About the author. Introduction. Confessions from an insider. Asthma deaths were caused by asthma inhalers. Shady marketing and research. Organised crime, the business model of big pharma. Hoffman-La Roche, the biggest drug pusher. Hall of Shame for big pharma. The crimes are repetitive. It's organised crime. Very few patients benefit from the drugs they take. Clinical trials, a broken social contract with patients. Conflicts of interest at medical journals. The corruptive influence of easy money. What do thousands of doctors on industry payroll do? Seeding trials. Rent a key opinion leader to 'give advice'. Rent a key opinion leader to 'educate'. Hard sell. Clinical trials are marketing in disguise. Ghostwriting. The marketing machine. Hard sell ad nauseam. Highly expensive drugs. Excesses in hypertension. Patient organisations. NovoSeven for bleeding soldiers. Impotent drug regulation. Conflicts of interest at drug agencies. Corruption at drug agencies. The unbearable lightness of politicians. Drug regulation builds on trust. Inadequate testing of new drugs. Too many warnings and too many drugs. Public access to data at drug agencies. Our breakthrough at the EMA in 2010. Access to data at other drug agencies. Deadly slimming pills. Neurontin, an epilepsy drug for everything. Merck, where the patients die first. Fraudulent celecoxib trial and other lies. Marketing is harmful. Switching cheap drugs into expensive ones in the same patients. Novo Nordisk switches patients to expensive insulin. Astra-Zeneca switches patients to expensive me-again omeprazole. Blood glucose was fine but the patients died. Novo Nordisk interferes with an academic publication. Psychiatry, the drug industry's paradise. Are we all crazy or what? Psychiatrists as drug pushers. The chemical imbalance hoax. Screening for psychiatric disorders. Unhappy pills. Prozac, a terrible Eli Lilly drug turned into a blockbuster. Exercise is a good intervention. Further lies about happy pills. Pushing children into suicide with happy pills. Glaxo study 329. Concealing suicides and suicide attempts in clinical trials. Lundbeck's evergreening of citalopram. Antipsychotic drugs. Zyprexa, another terrible Eli Lilly drug turned into a blockbuster. The bottomline of psychotropic drugs. Intimidation and threats to protect sales. Busting the industry myths. General system failure calls for a revolution. Our drugs kill us. How much medicine do we really need and at what cost?…